Showing 1 - 10 of 10
Persistent link: https://www.econbiz.de/10014317408
Persistent link: https://www.econbiz.de/10003792349
Persistent link: https://www.econbiz.de/10001666580
Persistent link: https://www.econbiz.de/10001579464
Persistent link: https://www.econbiz.de/10001240393
This paper examines the relationship between drug price and drug quality and how it varies across two of the most common regulatory regimes in the pharmaceutical market: Minimum Efficacy Standards (MES) and a mix of Minimum Efficacy Standards and Price Controls mechanisms (MES PC). Through a...
Persistent link: https://www.econbiz.de/10013114471
We assess the productivity growth of the English and Italian healthcare systems over the period from 2004 to 2011. The English (NHS) and the Italian (SSN) healthcare systems share many similar features, facilitating comparison: basic founding principles, financing, organization, management, and...
Persistent link: https://www.econbiz.de/10012941562
This paper examines the relationship between drug price and drug quality and how it varies across two of the most common regulatory regimes in the pharmaceutical market: minimum efficacy standards (MES) and a mix of minimum efficacy standards and price control mechanisms (MES+PC). Through a...
Persistent link: https://www.econbiz.de/10012464081
Persistent link: https://www.econbiz.de/10011924285
The aim of this article is to analyze the relationship between drug price and drug quality and how it varies across two of the most common regulatory regimes in the pharmaceutical market: Minimum Efficacy Standards (MES) and Price Controls (PC). We develop a model of adverse selection where a...
Persistent link: https://www.econbiz.de/10014212001